Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Vianet Group (VNET) by Steve Moore in ShareProphets
- Avoid Kromek Group (KMK) by Steve Moore in ShareProphets
- Buy NATWEST GROUP (NWG) by Bank of America
- Buy London Stock Exchange Group (LSEG) by Bank of America
- Hold AstraZeneca (AZN) by DZ Bank
- Avoid Trifast (TRI) by Steve Moore in ShareProphets
- Buy NATWEST GROUP (NWG) by Shore Capital
- Hold Central Asia Metals (CAML) by Canaccord Genuity
- Buy Oxford Metrics (OMG) by Canaccord Genuity
- Buy Atalaya Mining (ATYM) by Canaccord Genuity
- Hold BHP Group Limited NPV (DI) (BHP) by Berenberg
- Buy Taseko Mines Limited NPV (DI) (TKO) by Canaccord Genuity
- Underperform AB Dynamics (ABDP) by Jefferies
- Buy AstraZeneca (AZN) by Stifel
- Buy QinetiQ Group (QQ.) by John Fieldsend in The Motley Fool
- Hold Antofagasta (ANTO) by Canaccord Genuity
- Hold Reckitt Benckiser Group (RKT) by Deutsche Bank
- Hold London Stock Exchange Group (LSEG) by Deutsche Bank
- Hold AstraZeneca (AZN) by Deutsche Bank
- Reduce Convatec Group (CTEC) by Peel Hunt
Avacta Group (AVCT) Share Price
Health Care Sector
NOTE: This is based on 53 open tips for Avacta Group (AVCT)
| Latest Bid : 48.00p | Latest Ask : 49.00p |
| High Today : 49.40p | Low Today : 44.68p |
| This Years High : 159.60p | This Years Low : 44.50p |
| Volume : 4,678,270 | MKT Cap : £175.19M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
26/01/2016 – Stock Consolidation 100.000:1.000
Avacta Group (AVCT) Overview
Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION platforms.Avacta Group (AVCT) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Lucian Miers | Premium Only | 2023-12-24 13:45:00 24/12/2023 | 56.23% |
| Avoid | Kevin Godbold | Premium Only | 2022-10-24 15:35:00 24/10/2022 | 51.68% |
| Sell | Tom Winnifrith | Premium Only | 2022-10-18 14:10:00 18/10/2022 | 49.69% |
| Sell | Cat Jeeves | Premium Only | 2022-10-01 17:20:00 01/10/2022 | 54.18% |
| Sell | Tom Winnifrith | Premium Only | 2022-09-27 17:15:00 27/09/2022 | 53.74% |
Avacta Group (AVCT) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| GSA Capital Partners LLP | 0.6% | 24/04/2024 |
| Latest Bid : 48.00p | Latest Ask : 49.00p |
| High Today : 49.40p | Low Today : 44.68p |
| This Years High : 159.60p | This Years Low : 44.50p |
| Volume : 4,678,270 | MKT Cap : £175.19M |
Avacta Group Overview
Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION platforms.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Avacta Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Lucian Miers | Premium Only | 2023-12-24 13:45:00 24/12/2023 | 56.23% |
| Avoid | Kevin Godbold | Premium Only | 2022-10-24 15:35:00 24/10/2022 | 51.68% |
| Sell | Tom Winnifrith | Premium Only | 2022-10-18 14:10:00 18/10/2022 | 49.69% |
| Sell | Cat Jeeves | Premium Only | 2022-10-01 17:20:00 01/10/2022 | 54.18% |
| Sell | Tom Winnifrith | Premium Only | 2022-09-27 17:15:00 27/09/2022 | 53.74% |
Stock Splits and Consolidations
26/01/2016 – Stock Consolidation 100.000:1.000